Written by the Nuvirox Research Team
Key points
- Nearly all the usable energy in your body is made by one pathway: glucose or fat is broken down, electrons are stripped off, and those electrons drive ATP production in mitochondria.
- NAD+ is the shuttle. It is not the fuel and not the energy — it is the molecule that carries electrons from food breakdown to the machinery that makes ATP.
- You do not store ATP. You recycle roughly your own body weight in it every day, which is why supply interruptions are felt immediately.
Short answer: your body makes ATP by stripping electrons off food, handing them to a carrier molecule called NAD+, and using those electrons to pump protons across a mitochondrial membrane — then letting the protons flow back through a molecular turbine. That turbine is ATP synthase, and it physically rotates. The whole system is about as close to industrial engineering as biology gets, and understanding it makes almost every claim in the cellular energy supplement aisle easier to evaluate.
Why ATP and not something else?
Adenosine triphosphate is your cells’ universal energy currency because of a chemical accident of convenience: it carries three phosphate groups in a row, all negatively charged and all repelling each other. Snapping the outermost one off releases usable energy in a package sized correctly for most cellular jobs — contracting a muscle fibre, pumping ions across a membrane, building a protein.
The critical and frequently missed point is that ATP is not a storage molecule. Your body holds only a few seconds’ worth at any moment. What you actually do is cycle the same limited pool over and over: ATP is broken to ADP, then rebuilt to ATP, thousands of times per molecule per day. Turnover across a day runs to roughly the mass of your entire body. There is no reservoir to draw down, which is why any genuine disruption to production shows up as fatigue almost immediately rather than gradually.
What are the three stages?
Stage one is glycolysis, which happens in the cytoplasm and needs no oxygen. One glucose molecule is split into two pyruvate molecules, netting a small direct yield of ATP and, importantly, loading electrons onto NAD+ to form NADH.
Stage two is the Krebs cycle (also called the citric acid or TCA cycle), inside the mitochondrion. Pyruvate is converted and fed into a circular series of reactions that strip off carbon as carbon dioxide — the CO₂ you exhale — while loading many more electrons onto NAD+ and a related carrier, FAD. The cycle’s direct ATP output is small. Its real product is loaded electron carriers.
Stage three is the electron transport chain and oxidative phosphorylation, on the inner mitochondrial membrane. NADH delivers its electrons to a series of protein complexes that pass them down an energy gradient, using the released energy to pump protons into the intermembrane space. That builds an electrochemical gradient. Protons then flow back through ATP synthase, which spins and phosphorylates ADP into ATP. Oxygen sits at the very end of the chain as the final electron acceptor — which is the entire reason you breathe.
The three stages of aerobic respiration. NAD+ is the connective tissue between stages one, two and three.
Where exactly does NAD+ fit in?
NAD+ is the electron shuttle between food breakdown and ATP production. In its oxidised form (NAD+) it can accept electrons; carrying them, it becomes NADH; delivering them to the electron transport chain, it reverts to NAD+ and goes back for more. It is a courier, not cargo, which is why the distinction between NAD+ and NADH matters more than most marketing acknowledges — we unpack that separately in NADH vs. NAD+.
The consequence is that the ratio of NAD+ to NADH is one of the cell’s central regulatory signals. A 2023 meta-analysis of NAD(P)(H) quantification across mammalian tissues describes this ratio explicitly as an important indicator of intracellular redox state that regulates key metabolic pathways. NAD+ is also consumed — not merely recycled — by enzymes involved in DNA repair and cell signalling, which is why the body has to keep resynthesising it through the salvage pathway and, more slowly, from tryptophan through the de novo route.
What human studies actually show about the machinery slowing down
NAD+ metabolism does change with age in human tissue. Massudi and colleagues, publishing in PLoS ONE in 2012, examined age-associated changes in oxidative stress and NAD+ metabolism in human tissue and reported measurable shifts in the NAD+ system across the lifespan. This is one of the more frequently cited pieces of primary human evidence for the decline narrative.
A specific consumer of NAD+ ramps up with age. Camacho-Pereira and colleagues, in Cell Metabolism in 2016, showed that the enzyme CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. This matters mechanistically: it suggests age-related NAD+ loss is partly a demand problem, not only a supply problem.
The counterweight is that measurement itself is unreliable, and one large recent dataset disputes the premise. The 2023 Scientific Reports meta-analysis screened 4,890 records of NAD(P)(H) quantification and found substantial inter-method and intra-method variability that persisted into recent publications, concluding that cross-experimental comparison of NAD quantitative data has relatively poor potential. More pointedly, a 2026 Nature Metabolism analysis across seven independent human cohorts, using rigorously validated mass spectrometry, found whole-blood NAD+ levels remained remarkably stable with age. Anyone telling you confidently what your NAD+ “should” be at 45 is over-reading a contested literature — we go through this in detail in can you actually test your NAD+ levels.
What actually slows the assembly line down
Three bottlenecks are worth knowing, in rough order of how often they matter.
- Oxygen and substrate delivery. The chain terminates in oxygen. Anaemia, poor cardiorespiratory fitness or lung disease constrain the last step regardless of how well everything upstream works.
- Mitochondrial quantity and quality. Governed largely by the PGC-1α pathway; fewer or less efficient mitochondria means less capacity, which is why endurance training — which increases both — produces such disproportionate improvements in how energetic people feel.
- Cofactor availability. B vitamins, iron, magnesium and NAD+ precursors all feed the machinery. Genuine deficiency impairs output; topping up beyond sufficiency does not obviously increase it.
Notice what is not on that list: a general shortage of “energy” that can be topped up directly. You cannot swallow ATP usefully — it is degraded in the gut and does not reach cells intact. Any product promising to deliver cellular energy is really promising to remove a bottleneck, and the honest question is always which one.
Frequently asked questions
How much ATP does one glucose molecule produce?
Textbooks used to say 36–38; modern estimates are lower, generally around 30–32, because proton leak and the cost of transporting molecules across membranes were previously ignored. The exact figure varies with cell type and conditions, which is part of why the number was revised downward.
Can I take ATP as a supplement?
Not usefully. Oral ATP is broken down during digestion and does not arrive in cells as intact ATP. Supplements that plausibly affect this system work upstream, on precursors and cofactors, not on ATP itself.
Does more NAD+ mean more ATP?
Not automatically. NAD+ is required for the pathway, so a real shortfall would limit output. But adding more courier molecules to a system that already has enough couriers does not speed up the factory. Raising NAD+ is well established in trials; translating that into measurable ATP or performance gains is where the evidence gets thinner.
Why do I feel tired if ATP production is automatic?
Fatigue is generated by the brain, not directly by ATP levels, and it integrates sleep, inflammation, mood, illness and training load. Cellular energy supply is one input among many — often not the limiting one.
From Nuvirox
Why we formulated NAD+ Restore
NAD+ sits at the junction between food breakdown and ATP production, and human trials consistently show that precursors like nicotinamide riboside raise it. We formulated NAD+ Restore around that specific, well-replicated step — and we would rather be clear about where the evidence stops than imply it goes further than it does.
- 500 mg nicotinamide riboside chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
- 150 mg trans-resveratrol (Japanese knotweed) and 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support.
- 10 mg galactomannans from fenugreek — to support absorption.
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
The bottom line
ATP production is a three-stage pipeline that converts food into a rotating molecular turbine’s output, with NAD+ acting as the electron courier that links the stages. The chemistry is settled; what remains genuinely uncertain is how much of ordinary human fatigue is limited by this machinery versus by everything else. The fair reading is that the pathway is real, NAD+ is central to it, and the leap from “central to the pathway” to “supplementing it will make you feel energetic” is a leap the evidence has not yet fully made.
References
- Meta-analysis of NAD(P)(H) quantification results exhibits variability across mammalian tissues. Sci Rep. 2023. DOI: 10.1038/s41598-023-29607-8. PMCID: PMC9922293.
- Camacho-Pereira J, Tarragó MG, Chini CCS, Nin V, Escande C, Warner GM, Puranik AS, Schoon RA, Reid JM, Galina A, Chini EN. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metab. 2016;23:1127–1139.
- Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS ONE. 2012;7:e42357.
- Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle. J Physiol. 2003. PMID: 12563009.
- PGC-1α is dispensable for exercise-induced mitochondrial biogenesis in skeletal muscle. PLoS One. 2012;7(7):e41817. DOI: 10.1371/journal.pone.0041817.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.